| Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study A Gottschlich, Q Hong, L Gondara, MS Alam, DA Cook, RE Martin, M Lee, ... Cancer Epidemiology, Biomarkers & Prevention, OF1-OF8, 2024 | 1 | 2024 |
| Results of the Mini-Adaptive Sampling Test Run (MASTR) Experiment: Autonomous Vehicles, Drifters, Floats, ROCIS, and HF-Radar, to Improve Loop Current System Dynamics and … SF DiMarco, S Glenn, M Smith, B Jaimes de la Cruz, R Ramos, ... Offshore Technology Conference, D021S017R007, 2024 | | 2024 |
| Transformer les soins gynécologiques en cancérologie au Canada: Un accès équitable et fondé sur des données probantes pour tous 6 février 2024 G Hanley, JMA Ariadne, H de Hiller, D Huntsman, N McKinstry, G Stuart, ... | | 2024 |
| Transforming Canada’s Gynecologic Cancer Care: Evidence-Based, Equitable Access for All February 6, 2024 G Hanley, J McAlpine, AH de Hiller, D Huntsman, N McKinstry, G Stuart, ... | | 2024 |
| Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study A Gottschlich, L Gondara, LW Smith, JJ Anderson, D Cook, M Krajden, ... The Lancet Regional Health–Americas 26, 2023 | 5 | 2023 |
| Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases? D Barnes, N Mohammad, L Hoang, M Anglesio, RL Hollis, C Gourley, ... Gynecologic Oncology Reports 44, 101076, 2022 | | 2022 |
| Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV for Cervical Cancer (HPV FOCAL) trial A Gottschlich, L Gondara, LW Smith, D Cook, RE Martin, M Lee, ... International journal of cancer 151 (6), 897-905, 2022 | 8 | 2022 |
| Gynecologic Cancer InterGroup consensus recommendations on clinical research in ovarian cancer I Vergote, A Gonzalez-Martin, D Lorusso, C Gourley, MR Mirza, JE Kurtz, ... The Lancet. Oncology 23 (8), e374, 2022 | 2 | 2022 |
| Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup I Vergote, A Gonzalez-Martin, D Lorusso, C Gourley, MR Mirza, JE Kurtz, ... The Lancet Oncology 23 (8), e374-e384, 2022 | 64 | 2022 |
| Gynecologic cancer risk and genetics: informing an ideal model of gynecologic cancer prevention LC Tindale, A Zhantuyakova, S Lam, M Woo, JS Kwon, GE Hanley, ... Current Oncology 29 (7), 4632-4646, 2022 | 4 | 2022 |
| Colposcopy referral rates in an organized cytology-based cervix screening program after receipt of multiple rounds of HPV-based screening in the FOCAL trial A Gottschlich, JJ Anderson, L Gondara, M Lee, D Van Niekerk, LW Smith, ... Cancer Research 82 (12_Supplement), 6239-6239, 2022 | | 2022 |
| Willingness to self-collect a sample for HPV-based cervical cancer screening in a well-screened cohort: HPV FOCAL survey results A Lesack, LW Smith, CS Racey, L Gondara, M Krajden, M Lee, RE Martin, ... Current Oncology 29 (6), 3860-3869, 2022 | 4 | 2022 |
| Endoscopic optical coherence tomography (OCT) and autofluorescence imaging (AFI) of the endocervical canal for cervical cancer screening J Malone, S Lam, AL Buenconsejo, G Hohert, DM Miller, L Proctor, ... Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XX …, 2022 | | 2022 |
| Perceived barriers and facilitators to attendance for cervical cancer screening in EU member states: a systematic review and synthesis using the Theoretical Domains Framework G Stuart, D D’Lima Psychology & health 37 (3), 279-330, 2022 | 19 | 2022 |
| Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results LW Smith, CS Racey, L Gondara, M Krajden, M Lee, RE Martin, G Stuart, ... BMJ open 11 (10), e052084, 2021 | 10 | 2021 |
| Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial I Cromwell, LW Smith, K van Der Hoek, L Hedden, AJ Coldman, D Cook, ... Cancer Medicine 10 (9), 2996-3003, 2021 | 9 | 2021 |
| Assessing 10-year safety of a single negative HPV test for cervical cancer screening: evidence from FOCAL-DECADE cohort A Gottschlich, D van Niekerk, LW Smith, L Gondara, J Melnikow, DA Cook, ... Cancer Epidemiology, Biomarkers & Prevention 30 (1), 22-29, 2021 | 15 | 2021 |
| Fast Facts: Clinical Trials in Oncology: The fundamentals of design, conduct and interpretation A Hackshaw, GCE Stuart Karger Medical and Scientific Publishers, 2020 | 1 | 2020 |
| Making Changes in the Academic Incentive System: HIBAR Research Alliance Discussion Paper J Austin, R Berman, K Chau, J Davis, G Dilabio, D Hannah, V Lemieux, ... | 1 | 2020 |
| Disease detection at the 48‐month exit round of the HPV FOCAL cervical cancer screening trial in women per‐protocol eligible for routine screening AJ Coldman, D van Niekerk, M Krajden, LW Smith, D Cook, L Gondara, ... International Journal of Cancer 146 (7), 1810-1818, 2020 | 1 | 2020 |
